Neoadjuvant, perioperative, or adjuvant immunotherapy in resectable non-small cell lung cancer: How do I choose? Importance of immune biomarkers and molecular testing
Related Posts
Kanis JA, Johansson H, Harvey NC, Lorentzon M, Cauley JA, Crandall CJ, Huisman M, Khosla S, Kwok T, Mellström D, Orwoll ES, van Schoor NM,[...]
Griffee MJ, Kirsch RE, Rubin J, Peeler A, Hayanga JW, Chatterjee S, Dorsey D, Emeruwa IO, Goodwin ML, Rubin EB, Kim BS, Grant MC, Zaaqoq[...]
Sandhu AT, Furst A, Rodriguez F, Kalwani N, Maron D, Nallamshetty S, Din N, Zitko K, Khachatourian K, Skaar JR, Tonnu-Mihara I. Systemic Inflammation and[...]